Search Results - "Cellular Reprogramming Techniques - methods"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Safety Profile of Good Manufacturing Practice Manufactured Interferon γ‐Primed Mesenchymal Stem/Stromal Cells for Clinical Trials by Guess, Adam J., Daneault, Beth, Wang, Rongzhang, Bradbury, Hillary, La Perle, Krista M. D., Fitch, James, Hedrick, Sheri L., Hamelberg, Elizabeth, Astbury, Caroline, White, Peter, Overolt, Kathleen, Rangarajan, Hemalatha, Abu‐Arja, Rolla, Devine, Steven M., Otsuru, Satoru, Dominici, Massimo, O'Donnell, Lynn, Horwitz, Edwin M.

    ISSN: 2157-6564, 2157-6580, 2157-6580
    Published: United States Oxford University Press 01.10.2017
    Published in Stem cells translational medicine (01.10.2017)
    “…Mesenchymal stem/stromal cells (MSCs) are widely studied by both academia and industry for a broad array of clinical indications. The collective body of data…”
    Get full text
    Journal Article
  2. 2

    Applying hydrodynamic pressure to efficiently generate induced pluripotent stem cells via reprogramming of centenarian skin fibroblasts by Vosough, Massoud, Ravaioli, Francesco, Zabulica, Mihaela, Capri, Miriam, Garagnani, Paolo, Franceschi, Claudio, Piccand, Julie, Kraus, Marine R.-C., Kannisto, Kristina, Gramignoli, Roberto, Strom, Stephen C.

    ISSN: 1932-6203, 1932-6203
    Published: United States Public Library of Science 25.04.2019
    Published in PloS one (25.04.2019)
    “…Induced pluripotent stem cell (iPSC)-technology is an important platform in medicine and disease modeling. Physiological degeneration and disease onset are…”
    Get full text
    Journal Article
  3. 3

    Pancreatic Transdifferentiation Using β-Cell Transcription Factors for Type 1 Diabetes Treatment by Mahoney, Alexandra L. G., Nassif, Najah T., O’Brien, Bronwyn A., Simpson, Ann M.

    ISSN: 2073-4409, 2073-4409
    Published: Switzerland MDPI AG 08.07.2022
    Published in Cells (Basel, Switzerland) (08.07.2022)
    “…Type 1 diabetes is a chronic illness in which the native beta (β)-cell population responsible for insulin release has been the subject of autoimmune destruction…”
    Get full text
    Journal Article
  4. 4

    Generation of Induced Pluripotent Stem Cell-Like Lines from Human Pancreatic Ductal Adenocarcinoma by Kim, Jungsun, Zaret, Kenneth S

    ISSN: 1940-6029, 1940-6029
    Published: United States 2019
    “…Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, mainly because the tumors are detected too late for effective treatment or for developing…”
    Get more information
    Journal Article